Follow
Dawid Sigorski
Dawid Sigorski
Verified email at uwm.edu.pl
Title
Cited by
Cited by
Year
Impact of COVID-19 on anxiety levels among patients with cancer actively treated with systemic therapy
D Sigorski, P Sobczuk, M Osmola, K Kuć, A Walerzak, M Wilk, T Ciszewski, ...
ESMO open 5 (5), e000970, 2020
662020
Attitudes of patients with cancer towards vaccinations—results of online survey with special focus on the vaccination against COVID-19
A Brodziak, D Sigorski, M Osmola, M Wilk, A Gawlik-Urban, J Kiszka, ...
Vaccines 9 (5), 411, 2021
382021
Complexity of neural component of tumor microenvironment in prostate cancer
A Sejda, D Sigorski, J Gulczyński, W Wesołowski, J Kitlińska, ...
Pathobiology 87 (2), 87-99, 2020
182020
Malignant gliomas as second neoplasms in pediatric cancer survivors: neuropathological study
E Izycka-Swieszewska, E Bien, J Stefanowicz, E Szurowska, ...
BioMed Research International 2018, 2018
182018
Poly (ADP-Ribose) polymerase inhibitors in prostate cancer: molecular mechanisms, and preclinical and clinical data
D Sigorski, E Iżycka-Świeszewska, L Bodnar
Targeted Oncology 15 (6), 709-722, 2020
132020
Paraffin-embedded tissue as a novel matrix in metabolomics study: Optimization of metabolite extraction method
M Buszewska-Forajta, M Patejko, S Macioszek, D Sigorski, ...
Chromatographia 82 (10), 1501-1513, 2019
82019
Investigation of neural microenvironment in prostate cancer in context of neural density, perineural invasion, and neuroendocrine profile of tumors
D Sigorski, J Gulczyński, A Sejda, W Rogowski, E Iżycka-Świeszewska
Frontiers in Oncology 11, 2602, 2021
52021
Caspase-14—From biomolecular basics to clinical approach. A review of available data
A Markiewicz, D Sigorski, M Markiewicz, A Owczarczyk-Saczonek, ...
International Journal of Molecular Sciences 22 (11), 5575, 2021
42021
Renal cell carcinoma with alpha-fetoprotein secretion and tissue expression–A case report
D Sigorski, R Pęksa, W Rogowski, T Milewski, E Iżycka-Świeszewska
Polish Annals of Medicine 24 (2), 240-244, 2017
22017
skin manifestation of mantle cell lymphoma–case report and literature review
A Markiewicz, N Zdanowska, AB Owczarczyk-Saczonek, MM Markiewicz, ...
Dermatology Review/Przegląd Dermatologiczny 104 (6), 655-662, 2017
22017
Neural density and perineural invasion in prostate cancer
J Gulczynski, D Sigorski, W Wesolowski, J Wisniewski, M Wolowiec, ...
VIRCHOWS ARCHIV 473, S195-S196, 2018
12018
Cutaneous manifestations of breast cancer
AB Owczarczyk-Saczonek, D Sigorski, P Różanowski, A Markiewicz, ...
Dermatology Review/Przegląd Dermatologiczny 104 (5), 561-569, 2017
12017
Antibody–Drug Conjugates in Uro-Oncology
D Sigorski, P Różanowski, E Iżycka-Świeszewska, K Wiktorska
Targeted Oncology, 1-19, 2022
2022
Sympathetic nervous signaling dictates prostate cancer progression
D Sigorski, E Iżycka-Świeszewska
Cell Death Discovery 8 (1), 1-2, 2022
2022
The Poly (ADP-ribose) polymerase inhibitors in pancreatic cancer
K Zubik, J Talaśka, D Sigorski, S Nawrocki
Biuletyn Polskiego Towarzystwa Onkologicznego Nowotwory 7 (1), 34-43, 2022
2022
The heart as a rare colorectal cancer metastases location
D Sigorski, M Muzolf, P Jancewicz, P Różanowski
Nowotwory. Journal of Oncology 71 (6), 417-417, 2021
2021
Myeloablative chemotherapy in testicular cancer patient
K Furgała, Z Smuniewska, D Sigorski, M Michalak, L Bodnar
OncoReview 11 (1), 19-21, 2021
2021
1753P Coronavirus or cancer: What are oncological patients most afraid of?
DS Sigorski, P Sobczuk, K Kuć, M Osmola, A Walerzak, T Ciszewski, ...
Annals of Oncology 31, S1022, 2020
2020
1992P Significance of ERG status on neural microenvironment in prostate cancer
DS Sigorski, A Sejda, J Gulczyński, J Kitlińska, W Rogowski, ...
Annals of Oncology 31, S1114, 2020
2020
Porównanie poziomu lęku przeciwko nowotworowi i koronawirusowi u pacjentów leczonych onkologicznie podczas pandemii SARS-CoV-2 w Polsce
D Sigorski, P Sobczuk, K Kuć, M Osmola, A Walerzak, T Ciszewski, ...
Onkologia w Praktyce Klinicznej-Edukacja 6 (supl. G), 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–20